Changes in evaluation of the pepsinogen test result following Helicobacter pylori eradication therapy in Japan

Inflammopharmacology

Volumn 15, Issue 1, 2007, Pages 31-35

  Kawai, T ^a   Miki, K ^c   Ichinose, M ^d   Kenji, Y ^b   Miyazaki, I ^b   Kawakami, K ^b   Kataoka, M ^a   Yamagishi, T ^a   Sofuni, A ^b   Itoi, T ^b   Moriyasu, F ^b   Takagi, Y ^b   Aoki, T ^b   Matsubayashi, J ^a   Mukai, K ^a  

^a TOKYO MEDICAL UNIVERSITY HOSPITAL   (Japan)

^b TOKYO MEDICAL UNIVERSITY   (Japan)

^c TOHO UNIVERSITY   (Japan)

^d WAKAYAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Eradication; Helicobacter pylori; Pepsinogen

Indexed keywords

PEPSINOGEN; PEPSINOGEN I; PEPSINOGEN II;

ADULT; ARTICLE; BLOOD ANALYSIS; DIAGNOSTIC PROCEDURE; ENDOSCOPY; ERADICATION THERAPY; FEMALE; GASTROINTESTINAL SYMPTOM; HELICOBACTER PYLORI; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ANTI-BACTERIAL AGENTS; ANTI-ULCER AGENTS; FEMALE; GASTRIC MUCOSA; GASTROINTESTINAL DISEASES; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; PEPSINOGENS; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME;

EID: 33847338890     PISSN: 09254692     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10787-006-0009-y     Document Type: Article

References (27)

1. Cave, T. R., Cave, D. R. (1991. Helicobacter pylori stimulating pepsin secretion from isolated rabbit gastric glands, Scand. J. Gastroenterol. 26 (Suppl 181), 9-14.
2. Correa, P. (1992). Human gastric carcinogenesis: a multistep multifactorial process. First American Cancer Society Award lecture on cancer epidemiology and prevention, Cancer Res. 52, 6735-6740.
3. Dixon, M. F., Genta, R. M., Yardley, J. H., Correa, P. (1996). Classification and grading of gastritis the updated Sydney System, Am. J. Surg. Pathol. 20, 1161-1181.
4. Furuta, T., Kaneko, E., Baba, S., Arai, H., Futami, H. (1997). Percentage changes in serum pepsinogens are useful as indices of eradication of Helicobacter pylori. Am. J. Gastroenterol. 92, 84-88.
5. Haruma, K., Komoto, K., Kamada, T., Ito, T., Kitadai, Y., Yoshihara, M., Sumii, K., Kajiyama, G. (2000). Helicobacter pylori is a major risk factor for gastric carcinoma in young patients, Scand. J. Gastroenterol. 35, 255-259.
6. Ito, M., Haruma, K., Kamada, T., Mihara, M., Kim, S., Kitadai, Y., Sumii, M., Tanaka, S., Yoshihara, M., Chayama, K. (2002). Helicobacter pylori eradication therapy improves atrophic gastritis and intestinal metaplasia: a 5-year prospective study of patients with atrophic gastritis, Aliment Pharmacol. Ther. 16, 1449-1456.
7. Kawaguchi, H., Haruma, K., Komoto, K., Yoshihara, M., Sumi, K., Kajiyama, G. (1996). Helicobacter pylori infection is the major risk factor for atrophic gastritis, Am. J. Gastroenterol. 91, 959-962.
8. Kikuchi, S., Wada, O., Nakajima, T., Nishi, T., Kobayashi, O., Kinishi, T., Inaba, Y. (1995). Serum anti-Helicobacter pylori antibody and gastric carcinoma among young adults. Reaserch Group on Prevention of Gastric Caricinoma among Young Adalts, Cancer 75, 2789-2793.
9. Knight, T., Greaves, S., Wilson, A., Hengels, K., Newell, D., Coelett, M., Webb, P., Forman, D., Elder, J. (1995). Variability in serum pepsinogen levels in an asymptomatic population, Eur. J. Gastroenterol. Hepatol. 7, 647-654.
10. Kodoi, A., Yoshihara, M., Sumi, K., Haruma, K., Kajiyama, G. (1995). Serum pepsinogen in screening for gastric cancer, J. Gastroenterol. 30, 452-460.
11. Kuipers, E. J., Uyterlinde, A. M., Pena, A. S., Roosendaal, R., Plas, G., Nelis, G. F., Festen, H. P., Meuwissen, S. G. (1995). Long-term sequelae of Helicobacter pylori gastritis, Lancet 345, 1525-1528.
12. Lorente, S., Doiz, O., Trinidad Serrano, M., Castillo, J., Lanas, A. (2002). Helicobacter pylori stimulates pepsinogen secretion from isolated human peptic cells, Gut 50, 13-18.
13. Marshal, B. J., Warren, J. R. (1984). Unidentified curve bacilli in the stomach of patient with gastritis and peptic ulceration, Lancet 16, 1311-1314.
14. Miki, K., Ichinose, M., Ishikawa, K. B., Yahagi, N., Matsushima, M., Kakei, N., Tsukada, S., Kido, M., Ishihama, S., Shimizu, Y., Suzuki, T., Kurokawa, K. (1993). Clinical application of serum pepsinogen I and II levels for mass screening to detect gastric cancer, Jpn. J. Cancer Res. 10, 1086-1090.
15. Miki, K., Ichinose, M., Ishikawa, K. B., Yahagi, N., Matsushima, M., Kakei, N. et al. (1993). Clinical application of serum pepsinogen I and II levels for mass screening to detect gastric cancer, Jpn. J. Cancer Res. 10, 1086-1090.
16. Nomura, A., Stemmermann, G. N., Chyou, P. H., Kato, I., Perez-Perzz, G. I., Blaser, M. J. (1991). Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii, N. Engl. J. Med. 325, 1132-1136.
17. 13C-urea breath test for diagnosis of Helicobacter pylori infection in Japan, J. Gastroenterol. 33, 6-13.
18. Ohkusa, T., Fujiki, K., Takashimizu, I., Kumagai, J., Tanizawa, T., Eishi, Y., Yokoyama, T., Watanabe, M. (2001). Improvement in atrophic gastritis and intestinal metaplasia in patients in whom Helicobacter pylori was eradicated, Ann. Intern. Med. 134, 380-386.
19. Samloff, I. M., Varis, K., Ihamaki, T., Siurala, M., Rotter, J. I. (1982). Relationships among serum pepsinogen, serum pepsinogen, and gastric mucosal histology, Gastroenterology 83, 204-209.
20. Satoh, K., Kimura, K., Takimoto, T., Kihira, K. (1998). A follow-up study of atrophic gastritis and intestinal metaplasia after eradication of Helicobacter pylori, Helicobacter 3, 236-240.
21. Tsubono, Y., Hisamichi, S. (2000). Screening for gastric cancer in Japan, Gastric Cancer 3, 9-18.
22. Uemura, N., Mukai, T., Okamoto, S. et al. (1997). Effect of Helicobacter pylori eradication on subsequent development of cancer after endoscopic resection of early gastric cancer, Cancer Epidemiol. Biomarkers Prev. 6, 639-642.
23. Uemura, N., Okamoto, S., Yamamoto, S., Matsumura, N., Yamaguchi, S., Yamakido, M., Taniyama, K., Sasaki, N., Schlemper, R. J. (2001). Helicobacter pylori infection and the development of gastric cancer, N. Engl. J. Med. 345, 784-789.
24. Wagner, S., Haruma, K., Gladziwa, U., Soudah, B., Gebel, M., Bleck, J., Schimidt, H., Manns, M. (1994). Helicobacter pylori infection and serum pepsinogen A, pepsinogen C and gastrin in gastritis and peptic ulcer: significance of inflammation and effect of bacterial eradication, Am. J. Gastroenterol. 89, 1211-1218.
25. Watanabe, Y., Kurata, J. H., Mizuno, S., Murai, M., Inokuchi, H., Miki, K., Ozasa, K., Kawai, K. (1997). Helicobacter pylori infection and gastric cancer. A nested case-control study in a rural area of Japan, Dig. Dis. Sci. 42, 1383-1387.
26. Watase, H., Inagaki, T., Yoshikawa, I., Furihata, T., Watanabe, Y., Miki, K. (2004). Five years follow up study of gastric cancer screening using the pepsinogen test method in Adachi city (in Japanese, English abstract), Nihongankenshin shindangakkai kaishi 11, 77-81.
27. Wong, B. C. Y., Lam, S. K., Wong, W. M. et al. (2004). Helicobacter pylori eradication to prevent gastric cancer in high-risk region of China: a randomized control trial, JAMA 291, 187-194.